CWC
IDXX icon

Carolinas Wealth Consulting’s Idexx Laboratories IDXX Stock Holding History

Carolinas Wealth Consulting’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$3.78K – 436
2025
Q1 		$3.78K Hold
9
– – ﹤0.01% 652
2024
Q4 		$3.72K Hold
9
– – ﹤0.01% 689
2024
Q3 		$4.55K Sell
9
-114
-93% -$55.4K ﹤0.01% 676
2024
Q2 		$59.9K Buy
123
+37
+43% +$18.6K 0.01% 341
2024
Q1 		$46.4K Sell
86
-4
-4% -$2.19K 0.01% 387
2023
Q4 		$50K Sell
90
-19
-17% -$8.92K 0.01% 336
2023
Q3 		$43.5K Buy
109
+15
+16% +$7.48K 0.01% 327
2023
Q2 		$47.2K Sell
94
-6
-6% -$2.88K 0.01% 353
2023
Q1 		$50K Sell
100
-78
-44% -$37.3K 0.01% 360
2022
Q4 		$72.6K Buy
178
+48
+37% +$18.6K 0.02% 306
2022
Q3 		$42K Buy
130
+29
+29% +$10.7K 0.01% 352
2022
Q2 		$35K Buy
101
+30
+42% +$12.2K 0.01% 372
2022
Q1 		$39K Buy
+71
New +$37.3K 0.01% 381

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Carolinas Wealth Consulting's IDXX Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 9 shares — an estimated $3.78K sold.

Carolinas Wealth Consulting first reported a position in IDXX in Q1 2022 and held it in 13 quarters. The position peaked at $72.6K in Q4 2022. 1,235 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 9 Idexx Laboratories shares in Q2 2025, an estimated $3.78K.
  • Carolinas Wealth Consulting first reported a position in Idexx Laboratories in Q1 2022 and held it in 13 quarters.
  • Carolinas Wealth Consulting's Idexx Laboratories position peaked at $72.6K in Q4 2022.
  • 1,235 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.